除顫器市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

Defibrillators Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年01月02日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2024 年全球除顫器市場規模將達到 136 億美元，預計 2025 年至 2034 年期間複合年成長率將達到 5.4%。這一穩定成長主要得益於心血管疾病發病率不斷上升、人們對救生醫療設備認知不斷提高以及全球人口老化。由於心臟相關疾病仍然是全球主要死亡原因之一，對除顫器的需求持續上升。此外，包括自動體外心臟去顫器 (AED) 和植入式心臟復律去顫器 (ICD) 的發展在內的技術進步，使得這些救生設備更加有效、更方便用戶使用。尤其是 AED，越來越被視為公共衛生計畫中的重要工具，越來越多的公共場所和醫療設施配備了這些設備。政府的政策和措施也推動了這一趨勢，這些政策和措施旨在改善基本救生設備的獲取，最終縮短對心臟驟停和其他心臟相關緊急情況的反應時間。

除顫器市場根據產品類型進行細分，包括植入式心臟復律去顫器 (ICD) 和外部心臟復律去顫器。 ICD 旨在持續監測心律並在必要時發出電擊以防止心臟驟停，預計在預測期內的複合年成長率為 5.2%。到 2034 年，該領域預計將創造 167 億美元的市場價值。 ICD 的廣泛應用，特別是在高風險患者群體和臨床環境中，凸顯了其在拯救生命方面的關鍵作用。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	136億美元
預測值	238億美元
複合年成長率	5.4%

從終端用戶來看，醫院在除顫器市場佔據主導地位，2024 年佔 67.8% 的佔有率。醫院仍然是急救和重症監護的主要場所，先進的除顫器設備對於快速應對心臟緊急情況是必不可少的。訓練有素的醫療專業人員的存在進一步推動了這些環境中除顫器的採用。此外，其他醫療機構，如門診手術中心，也正在增加對這些救生技術的投資，促進市場的更廣泛成長。

在美國，除顫器市場在 2024 年創造了 46 億美元的收入，預計到 2034 年將以 4.5% 的複合年成長率成長。美國受益於強大的醫療保健基礎設施、對醫療技術的大量投資以及鼓勵廣泛使用除顫器的支持性政策。公共和私營部門的舉措正在推動將 AED 整合到公共場所和醫療設施中，最終透過提高對心臟驟停的緊急響應速度和效率來提高存活率。

產業生態系統分析
產業衝擊力
- 成長動力
  - 心臟病盛行率上升
  - 技術進步與創新設備的引進
  - 提高大眾意識
  - 穿戴式心臟復律去顫器的需求不斷增加
- 產業陷阱與挑戰
  - 設備成本高
  - 產品召回
成長潛力分析
監管格局
按地區進行定價分析
管道產品
啟動場景
報銷場景
技術格局
差距分析
波特的分析
PESTEL 分析
指示景觀
- 植入式心臟復律去顫器 (ICD)
- 穿戴式體外心臟復律去顫器 (WCD)

第4章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
策略儀表板

第 5 章：市場估計與預測：按產品，2021 - 2034 年

主要趨勢
植入式心臟復律去顫器 (ICD)
- 經靜脈植入式心臟復律去顫器
  - 雙腔 ICD
  - 單腔 ICD
- 皮下植入式心臟復律去顫器
體外心臟復律去顫器
- 手動 ED
- 自動化 ED
  - 半自動體外心臟去顫器
  - 全自動體外心臟去顫器
- 穿戴式心臟復律去顫器

第6章：市場估計與預測：依最終用途，2021 - 2034 年

主要趨勢
醫院
門診手術中心
其他最終用戶

第7章：市場估計與預測：按地區，2021 - 2034 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第8章：公司簡介

Abbott
Amiitalia
Asahi KASEI
BIOTRONIK
Boston Scientific
BPL Medical Technologies
CU MEDICAL
MEDITECH
Medtronic
MicroPort
mindray
NIHON KOHDEN
Philips
SCHILLER
Stryker

簡介目錄

Product Code: 5495

The Global Defibrillators Market is expected to reach USD 13.6 billion by 2024 and is projected to grow at a robust CAGR of 5.4% from 2025 to 2034. This steady growth is largely driven by the increasing prevalence of cardiovascular diseases, growing awareness of life-saving medical devices, and an aging population worldwide. As heart-related conditions remain one of the leading causes of death globally, the demand for defibrillators continues to rise. Additionally, advancements in technology, including the development of automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs), are making these life-saving devices more effective and user-friendly. AEDs, in particular, are increasingly seen as a crucial tool in public health initiatives, with more public spaces and medical facilities being equipped with these devices. This trend is also fueled by government policies and initiatives aimed at improving access to essential life-saving devices, ultimately enhancing response times to sudden cardiac arrest and other heart-related emergencies.

The defibrillators market is segmented based on product types, including implantable cardioverter defibrillators (ICDs) and external cardioverter defibrillators. ICDs designed to continuously monitor heart rhythms and deliver shocks when necessary to prevent sudden cardiac arrest, are projected to experience a CAGR of 5.2% over the forecast period. By 2034, this segment is expected to generate a market value of USD 16.7 billion. The widespread adoption of ICDs, particularly in high-risk patient populations and clinical settings, underscores their critical role in saving lives.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$13.6 Billion
Forecast Value	$23.8 Billion
CAGR	5.4%

In terms of end users, hospitals dominate the defibrillator market, holding a substantial share of 67.8% in 2024. Hospitals remain the primary settings for emergency and critical care, where advanced defibrillator devices are indispensable for swift response to cardiac emergencies. The availability of trained medical professionals further drives the adoption of defibrillators in these environments. Additionally, other healthcare facilities, such as ambulatory surgical centers, are increasingly investing in these life-saving technologies, contributing to the broader growth of the market.

In the U.S., the defibrillators market generated USD 4.6 billion in 2024 and is expected to grow at a CAGR of 4.5% through 2034. The U.S. benefits from a strong healthcare infrastructure, substantial investments in medical technologies, and supportive policies that encourage the widespread use of defibrillators. Public and private sector initiatives are driving the integration of AEDs into public spaces and healthcare facilities, ultimately improving survival rates by enhancing the speed and efficiency of emergency responses to sudden cardiac arrest.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of cardiac diseases
  - 3.2.1.2 Technological advancements and introduction of innovative devices
  - 3.2.1.3 Increasing public awareness
  - 3.2.1.4 Increasing demand for wearable cardioverter defibrillators
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of the devices
  - 3.2.2.2 Product recall
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pricing analysis, by region
- 3.5.1 North America
- 3.5.2 Europe
- 3.5.3 Asia Pacific
- 3.5.4 Latin America
- 3.5.5 MEA
3.6 Pipeline products
3.7 Startup scenario
3.8 Reimbursement scenario
3.9 Technology landscape
3.10 Gap analysis
3.11 Porter's analysis
3.12 PESTEL analysis
3.13 Indication landscape
- 3.13.1 Implantable cardioverter defibrillators (ICDs)
- 3.13.2 Wearable external cardioverter defibrillators (WCDs)

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1 Key trends
5.2 Implantable cardioverter defibrillator (ICD)
- 5.2.1 Transvenous implantable cardioverter defibrillator
  - 5.2.1.1 Dual-chamber ICDs
  - 5.2.1.2 Single-chamber ICDs
- 5.2.2 Subcutaneous implantable cardioverter defibrillator
5.3 External cardioverter defibrillator
- 5.3.1 Manual ED
- 5.3.2 Automated ED
  - 5.3.2.1 Semi-automated external defibrillator
  - 5.3.2.2 Fully automated external defibrillator
- 5.3.3 Wearable cardioverter defibrillator

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

6.1 Key trends
6.2 Hospitals
6.3 Ambulatory surgical centers
6.4 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE